ES512629A0 - Procedimiento para preparar una sal de pirimidona. - Google Patents

Procedimiento para preparar una sal de pirimidona.

Info

Publication number
ES512629A0
ES512629A0 ES512629A ES512629A ES512629A0 ES 512629 A0 ES512629 A0 ES 512629A0 ES 512629 A ES512629 A ES 512629A ES 512629 A ES512629 A ES 512629A ES 512629 A0 ES512629 A0 ES 512629A0
Authority
ES
Spain
Prior art keywords
pirimidone
salt
preparing
procedure
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES512629A
Other languages
English (en)
Spanish (es)
Other versions
ES8304094A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of ES8304094A1 publication Critical patent/ES8304094A1/es
Publication of ES512629A0 publication Critical patent/ES512629A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Air-Conditioning For Vehicles (AREA)
ES512629A 1981-05-30 1982-05-28 Procedimiento para preparar una sal de pirimidona. Granted ES512629A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8116615 1981-05-30

Publications (2)

Publication Number Publication Date
ES8304094A1 ES8304094A1 (es) 1983-02-16
ES512629A0 true ES512629A0 (es) 1983-02-16

Family

ID=10522169

Family Applications (1)

Application Number Title Priority Date Filing Date
ES512629A Granted ES512629A0 (es) 1981-05-30 1982-05-28 Procedimiento para preparar una sal de pirimidona.

Country Status (12)

Country Link
US (1) US4450161A (Direct)
EP (1) EP0067579B1 (Direct)
JP (1) JPS57206683A (Direct)
AT (1) ATE9345T1 (Direct)
AU (1) AU8431082A (Direct)
DE (1) DE3260719D1 (Direct)
DK (1) DK230482A (Direct)
ES (1) ES512629A0 (Direct)
GB (1) GB2112380A (Direct)
GR (1) GR76450B (Direct)
PT (1) PT74958B (Direct)
ZA (1) ZA823766B (Direct)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4145546A (en) * 1975-10-02 1979-03-20 Smith Kline & French Laboratories Limited 4-Pyrimidone compounds
PH16240A (en) * 1978-04-11 1983-08-11 Smith Kline French Lab Process for making histamine antagonist
US4352933A (en) * 1981-02-06 1982-10-05 Smithkline Beckman Corporation Chemical methods and intermediates for preparing substituted pyrimidinones

Also Published As

Publication number Publication date
EP0067579B1 (en) 1984-09-12
GR76450B (Direct) 1984-08-10
EP0067579A1 (en) 1982-12-22
ES8304094A1 (es) 1983-02-16
JPS57206683A (en) 1982-12-18
DK230482A (da) 1982-12-01
AU8431082A (en) 1982-12-09
GB2112380A (en) 1983-07-20
US4450161A (en) 1984-05-22
ZA823766B (en) 1983-04-27
PT74958B (en) 1983-12-23
PT74958A (en) 1982-06-01
DE3260719D1 (en) 1984-10-18
ATE9345T1 (de) 1984-09-15

Similar Documents

Publication Publication Date Title
DE3162445D1 (de) 3-aryloxy-3-phenylpropylamines
YU164791A (sh) Nezasićene hidroksialkilhinolin kiseline
CO4820391A1 (es) Compuestos hipolipidemicos de benzotiazepina
CY1107238T1 (el) Παρασκευη μιας πολυμορφικης μορφης ενος παραγωγου θειαζολιδινοδιονης
IT1171880B (it) Derivati di 2-ammino-3-acilammino-6-benzilammino-piridina aventi azione antiepilettica e procedimento per la loro produzione
GB2123830A (en) Trisubstituted diazo compounds
DE2966030D1 (en) Antisecretory heterocyclic guanidine derivatives, process for their manufacture and pharmaceutical compositions containing them
IE790364L (en) 2-nitro aminopyrimidone derivatives
DK163360C (da) Fremgangsmaade til fremstilling af krystallinske vandoploeselige salte af cefodizim
ES512629A0 (es) Procedimiento para preparar una sal de pirimidona.
FI812470L (fi) 7-beta-/alfa-syn-metoxi-imino-alfa-(2-aminotiatsol-4-yl)acetamido)-3-((1,2,3-tiadiatsol-5-yltio)metyl)-3-cefem-4-karboxylsyra och dess c1-6-alkylderivat
IT1206130B (it) Composti per abbassare i livelli dei lipidi.
DK15290A (da) Cholestadienderivat som mellemprodukt til brug ved fremstillingen af homovitamin-d3-derivater
MX5446E (es) Procedimiento para la preparacion de derivados de 2-(fenoxi-alquilo)-2-imidazolinas substituidas por 1-iminometileno
BR0013235A (pt) Processo para a preparação de derivados de tiazol
ES500980A0 (es) Procedimiento de preparar alcoxi propanolaminas
IT8221939A0 (it) Immidazolil-propionitrili, procedimento per la preparazione di questi composti nonche' mezzi biocidi che li contengono.
ES499864A0 (es) Procedimiento para la preparacion de nuevas cefalosporinas
SE8107680L (sv) Piperazinderivat och forfarande for framstellning derav
ES511869A0 (es) Procedimiento para preparar derivados de acido 5-aminometil-2,3-dihidro-2-oxo-1h-imidazol-4-carboxilico.
FI832246A0 (fi) Foerfarande foer framstaellning av n-/2-(((5-(dimetylamino)-metyl-2-furanyl)-metyl)-tio)-etyl/-n'-metyl-2-nitro-1,1-etendiamin
ES494417A0 (es) Procedimiento para la preparacion de 2-(2-cloro-4-ciclopro- pil-fenil-imino)-imidazolidina
ES506022A0 (es) Un procedimiento para la preparacion de derivados acilicos de cefalosporina
EP0128437A3 (en) Nortropine derivative, process for its preparation and its use
ES544710A0 (es) Procedimiento para la obtencion de iminosulfonamidas